Relationship of sFas with metabolic risk factors and their clusters

European Journal of Clinical Investigation

Volumn 40, Issue 6, 2010, Pages 527-533

  Tamakoshi, Akiko ^a   Suzuki, Koji ^b   Lin, Yingsong ^a   Ito, Yoshinori ^c   Yagyu, Kiyoko ^a   Kikuchi, Shogo ^a   Watanabe, Yoshiyuki ^d   Inaba, Yutaka ^e   Tajima, Kazuo ^f   Nakachi, Kei ^g  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e JISSEN WOMEN'S UNIVERSITY   (Japan)

^f Cancer Center Research Institute   (Japan)

^g RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

Metabolic risk factors; SFas

Indexed keywords

FAS ANTIGEN;

ADULT; AGED; APOPTOSIS; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR;

ALCOHOL DRINKING; ANTIGENS, CD95; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; DIABETES MELLITUS; DIET; EDUCATIONAL STATUS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; METABOLIC DISEASES; OBESITY; OVERWEIGHT; RISK FACTORS; SMOKING; WALKING;

EID: 77952643786     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02293.x     Document Type: Article

References (27)

1. Cipollone F, Fazia ML, Mezzetti A. Oxidative stress, inflammation and atherosclerotic plaque development. Int Congr Ser 2007 1303: 35 40.
2. Danesh J, Wheeler J, Hirschfield G, Eda S, Eiriksdottir G, Rumley A et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004 350: 1387 1397.
3. Iso H, Cui R, Date C, Kikuchi S, Tamakoshi A, for the JACC Study Group. C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study. Atherosclerosis 2009 207: 291 297.
4. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004 114: 1752 1761.
5. Harrison D, Griendling K, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003 91: 7A 11A.
6. Feldkamp J, Pascher E, Schott M, Goretzki P, Seissler J, Scherbaum W. Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease. J Clin Endocrinol Metab 2001 86: 4250 4253.
7. Hao J, Ye D, Zhang G, Liu H, Dai H, Huang F et al. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese. Arch Dermatol Res 2006 297: 329 332.
8. Dalboni M, Sardenberg C, Andreoli M, Watanabe R, Canziani M, dos Santos B et al. Soluble Fas: a novel marker of inflammation in uremia. Artif Organs 2003 27: 687 691.
9. Troyanov S, Hebert MJ, Masse M, Vigneault N, Sirois I, Madore F. Soluble Fas: a novel predictor of atherosclerosis in dialysis patients. Am J Kidney Dis 2003 41: 1043 1051.
10. Tamakoshi A, Nakachi K, Ito Y, Lin Y, Yagyu K, Kikuchi S et al. Soluble Fas level and cancer mortality: findings from a nested case-control study within a large-scale prospective study. Int J Cancer 2008 123: 1913 1916.
11. Ohno Y, Tamakoshi A, for the JACC Study Group. Japan Collaborative Cohort Study for evaluation of cancer risk sponsored by Monbusho. J Epidemiol 2001 11: 144 150.
12. Tamakoshi A, Yoshimura T, Inaba Y, Ito Y, Watanabe Y, Fukuda K et al. Profile of the JACC Study. J Epidemiol 2005 15 (Suppl. 1 S4 8.
13. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA 2001 285: 2486 2497.
14. Ito Y, Nakachi K, Imai K, Hashimoto S, Watanabe Y, Inaba Y et al. Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study. J Epidemiol 2005 15 (Suppl. 1 S67 73.
15. Hebert MJ, Masse M, Vigneault N, Sirois I, Troyanov S, Madore F. Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease. Am J Kidney Dis 2001 38: 1271 1276.
16. Blanco-Colio LM, Martin-Ventura JL, de Teresa E, Farsang C, Gaw A, Gensini G et al. Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) Study, a substudy of ACTFAST. Arterioscler Thromb Vasc Biol 2007 27: 168 174.
17. Cui R, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S et al. Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study. Atherosclerosis 2007 194: 415 420.
18. Cui R, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S et al. Body mass index and mortality from cardiovascular disease among Japanese men and women: the JACC study. Stroke 2005 36: 1377 1382. (Pubitemid 40967497)
19. Iso H, Sato S, Kitamura A, Imano H, Kiyama M, Yamagishi K et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 2007 38: 1744 1751.
20. Nagata S. Apoptosis by death factor. Cell 1997 88: 355 365.
21. Owen-Schaub L, Chan H, Cusack J, Roth J, Hill L. Fas and Fas ligand interactions in malignant disease. Int J Oncol 2000 17: 5 12.
22. Doughty L, Clark R, Kaplan S, Sasser H, Carcillo J. sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome. Pediatr Res 2002 52: 922 927.
23. Festa A, D'Agostino R Jr., Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes 2001 25: 1407 1415.
24. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome; a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006 23: 469 480.
25. Ko GT, Cockram CS, Chow CC, Yeung V, Chan WB, So WY et al. High prevalence of metabolic syndrome in Hong Kong Chinese-comparison of three diagnostic criteria. Diabetes Res Clin Pract 2005 69: 160 168.
26. Wada K, Yatsuya H, Ouyang P, Otsuka R, Mitsuhashi H, Takefuji S et al. Self-reported medical history was generally accurate among Japanese workplace population. J Clin Epidemiol 2009 62: 306 313.
27. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004 57: 1096 1103.